REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Deepflare Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Data Processing, Hosting, and Related Services | Other Information Services | Internet Publishing and Broadcasting and Web Search Portals | Computer Systems Design and Related Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services
Full name: Deepflare Sp. z o.o. Profile Updated: April 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Deepflare is a company that specializes in in silico neoantigen discovery system using advanced computational algorithms to develop personalized cancer therapies. The company aims to accelerate vaccine discovery with AI.

Headquarters
Ul. Zlota 7/28
Warsaw; Mazowieckie; Postal Code: 00-019

Contact Details: Purchase the Deepflare Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Deepflare Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Deepflare Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Deepflare Sp. z o.o. report to view the information.
Incorporation Date:
June 17, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
25.86%
Purchase this report to view the information.
25.86%
Purchase this report to view the information.
25.86%
Purchase this report to view the information.
18.99%
Company Performance
Financial values in the chart are available after Deepflare Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
22.66%▲
Total operating revenue
-69.02%▼
Operating Profit/Loss (EBIT)
-28.38%▼
EBITDA
-28.38%▼
Net Profit/Loss for the Period
-29.03%▼
Total Assets
-56.77%▼
Total Equity
N/A
Operating Profit Margin (ROS)
-20.75%▼
Net Profit Margin
-23.18%▼
Return on Equity (ROE)
N/A
Debt/Equity
N/A
Quick Ratio
6%▲
Cash Ratio
6.52%▲

Similar companies

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy
 
Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy
Pit-Radwar S.A.
 
Naukowa I Akademicka Siec Komputerowa - Panstwowy Instytut Badawczy
"Novo Nordisk Pharma" Sp. z o.o.
 
Siec Badawcza Lukasiewicz-Instytut Lotnictwa
Lymelab Pharma Sp. z o.o.
 
Incellvu S.A.
Medrise Sp. z o.o.
 
Inovintell Sp. z o.o.
Tramag Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo